Canada makes deal to reduce generic drug pricesBMJ 2018; 360 doi: https://doi.org/10.1136/bmj.k723 (Published 14 February 2018) Cite this as: BMJ 2018;360:k723
- Owen Dyer
The prices of 70 of the most commonly prescribed generic drugs in Canada will fall by 25-40% on 1 April in a deal between Canada’s provinces and territories, working together, and the Canadian Generic Pharmaceutical Association.
The provinces extracted the concession by threatening to resort to tendering when ordering generics for their drug formularies, which would have forced makers to compete on price. Manufacturers have avoided this only by conceding widespread price reductions and by promising to publish all of their prices in the future so that each buyer can see what others are paying.
The reductions …